Personal record-keeping and educational reference. 18+. The app does not recommend substances, doses or treatment, or determine whether a substance is safe, approved or appropriate for you. Consult a qualified healthcare professional about decisions involving your health.
‹ Library

IGF-1 DES

Growth Factor (IGF/MGF)Research Use Only

Also known as: IGF-1 DES(1-3), DES(1-3) IGF-1

A faster, shorter-lived form of IGF-1 studied for localized muscle growth — but with no published human dosing protocol.

Dosing quick reference

research reference
No published human dosing protocol exists for this compound — reference sources list preclinical data only. Ranges you see elsewhere online are not evidence-based.
No published human protocol — preclinical data only. Online ranges are not evidence-based (per peptidedosages.com).
Half-life
~20–30 minutes (short-acting)
Route
Subcutaneous or intramuscular (research)
Common use
Studied as a short-acting, high-potency IGF-1 analog in localized growth-signaling research
Common vial sizes
1 mg
Storage
Lyophilized powder stored frozen or refrigerated away from light; reconstituted solution refrigerated (2–8 °C) and used within a few weeks
Stacking notes
Sometimes discussed alongside IGF-1 LR3 or growth-hormone secretagogues in research contexts

Reported side effects

Hypoglycemia-type symptoms cited in studiesInjection-site reactionLightheadedness reported anecdotally
Regulatory note: Not an approved therapeutic; prohibited in competitive sport under WADA; sold for research purposes only
Calculate a dose →IGF-1 DES on The Peptide Guide →Deeper research reference: literature dose ranges, storage and handling, and where to source in Canada.

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.